Meetings Events & Conference Coordinators 19th Annual New Orleans Summer Cancer Meeting 2024

Description Include: 57 videos, size: 7.52 GB Target Audience: oncologists, hematologists, radiation oncologists, surgical oncologists Sample video: contact me for sample video Information: The 19th Annual New Orleans Summer Cancer Meeting (NOSCM) 2024 will take place from July 19-21, 2024, at The Roosevelt Hotel in New Orleans, Louisiana. This event will focus on improving cancer survival rates through prevention, early detection, targeted therapy, and comprehensive survivorship care. The program will cover a wide range of topics, including advancements in cancer genetics, neuro-oncology, gastrointestinal and genitourinary cancers, immunotherapy, and more. The 19th Annual New Orleans Summer Cancer Meeting (NOSCM) 2024 is designed for a diverse group of professionals involved in oncology. The target audience includes: Oncologists Hematologists Radiation oncologists Surgical oncologists Medical oncologists Oncology nurses Pharmacists Researchers Other healthcare professionals involved in cancer care This meeting aims to provide the latest updates and advancements in cancer treatment, prevention, and survivorship care.   Topics: Acquired Inhibitors in Cancer- State-of-the Art Management.mp4 Addressing Disparities in Access to Supportive Care During Cancer Treatment and Survivorship- An Integrative Approach.mp4 ALK- First Line and Mechanism Of Resistance.mp4 Antibody Drug Conjugates for HER2 Negative Breast Cancer- A Revolution in Chemotherapy for Breast Cancer.mp4 Applying New Endocrine and Targeted Agents to the Treatment of Hormone Receptor Positive, HER2 Negative Breast Cancer.mp4 Artificial Intelligence and Modern Medical Practice- Do’s and Don’ts.mp4 Bladder Cancer- Novel Insights and Recent Approvals.mp4 Cancer Care Disparities in Puerto Rico.mp4 Cancer Genetic Risk Factors- What’s New and What You Need to Know..mp4 CAR-T Cell Therapy in Lymphomas- 7-Years Later.mp4 Challenges in Lung Cancer Pathology- Biomarkers.mp4 CLL- Therapeutic Advances in 2024.mp4 Colorectal Cancer- Novel Treatment Paradigms.mp4 Controversies in Colon Cancer- ctDNA in the Adjuvant Therapy of Colon Cancer and in the Management of Oligometastases (Against).mp4 Controversies in Colon Cancer- ctDNA in the Adjuvant Therapy of Colon Cancer and in the Management of Oligometastases (in Favor).mp4 Controversy in Breast Cancer- Should be pCR Be an Acceptable Endpoint for Approval of New Therapies for Early-Stage Breast Cance.mp4 Controversy in Breast Cancer- Should be pCR Be an Acceptable Endpoint for Approval of New Therapies for Early-Stage Breast Cance_2.mp4 Cost and Access to Novel Therapeutic Agents. Where Are The Obstacles..mp4 ctDNA in Lung Cancer- Current State and Future Perspectives.mp4 De Novo Acute Myeloid Leukemia.mp4 Diabetes Management in the Face of Healthcare Disparities.mp4 EGFR Exon 20 Insertions- Novel Agents.mp4 End of Life Management- Oncologists’ Perspectives.mp4 Equity and Equality for Minorities in Cancer Care.mp4 Immunotherapy for Breast Cancer- Efficacy and Toxicity Considerations.mp4 K-RAS Therapies in NSCLC.mp4 Kidney Cancer- Novel Development in Targeted and Immunotherapy.mp4 Leveraging NCODA Resources to Manage Patients on Oral Oncolytics.mp4 Lifestyle Modifications in Reducing Risk of Recurrence.mp4 los-noscm-2024-flyer.pdf Lung Cancer With EGFR Exon 19 and L858R Mutations- The Optimal Front Line Therapy.mp4 Malignant Hematology and Use of Bi-specifics in Puerto Rico.mp4 Melanoma- Novel Advances in Immunotherapy.mp4 Metastatic Castration Resistant Prostate Cancer- Sequencing the Treatment.mp4 Navigating Mantle Cell Lymphoma in the Era of Targeted Therapy.mp4 Neuro-Oncology- Novel Advances in Therapy.mp4 Neurology Drug Update.mp4 New and Evolving Directions in the Treatment of HER2 Positive Breast Cancer.mp4 Non Driver NSCLC-The Immunotherapy Strategy.mp4 Novel Advances for Thyroid Carcinoma and Thymoma.mp4 Novel Advances in T-Cell NHL Therapies.mp4 Obesity Management with Incretin Therapies- Considerations for Patients with and without Type 2 Diabetes.mp4 Optimal Surgical Approach in Early Stages NSCLC.mp4 Other Driver Mutations- ROS-1, BRAF, MET and RET.mp4 Pancreas, Hepatic and Cholangiocarcinoma- Advances in 2024.mp4 Pharmacology I- What HemOnc Clinicians Must Know in Immunotherapy.mp4 Prostate Cancer- Early and Locally Advanced Disease.mp4 Role of Pharmacist in Vaccination–Challenges and Opportunities.mp4 Screening in Lung Cancer- Challenges and Obstacles.mp4 Sequencing Therapy in Relapsed-Refractory Myeloma Patients.mp4 Small Cell Lung Cancer- Targeting This Difficult Target.mp4 Soft Tissue and Osteosarcomas- Novel Advances in 2024.mp4 Targeted Therapy in Hema Malignancies (CD20, CD30, CD33, BCR-ABL, FLT3, IDH1-2).mp4 Testicular Cancer- The Old, The New, The Future.mp4 Upfront Treatment for Common Ovarian Cancer (High Grade Serous) Versus Rare Histologies– Focus on PARPi and Other Targeted Ther.mp4 Upper GI Cancer- Esophageal and Gastric-New Developments.mp4 What Is Next After Osimertinib Progression..mp4